Access cutting-edge post-transplant lymphoproliferative disorder treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Columbus location
Access post-transplant lymphoproliferative disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related post-transplant lymphoproliferative disorder treatment provided free
Check if you qualify for this post-transplant lymphoproliferative disorder clinical trial in Columbus, OH
No-Cost Study Care
Local to Columbus
Convenient for OH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II trial tests how well tafasitamab and rituximab work for front-line treatment of patients with post-transplant lymphoproliferative disorder. Post-transplant lymphoproliferative disorder (PTLD) is the name for types of lymphoma that sometimes develop in people who have had a transplant. It can affect people who are taking medicines to suppress their immune system. Tafasitamab injection is in a class of medications called monoclonal antibodies. It works by helping the body to slow or
Sponsor: Timothy Voorhees
Yes, this clinical trial (NCT05786040) has an active research site in Columbus, OH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for post-transplant lymphoproliferative disorder treatment options in Columbus, OH, this clinical trial (NCT05786040) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced post-transplant lymphoproliferative disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all post-transplant lymphoproliferative disorder clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Columbus — not just this study.
Browse Rheumatoid Arthritis Trials in Columbus →